Nestlé is betting big on the booming weight loss drug market, leveraging AI and nutrition science to create muscle-preserving, hunger-curbing products tailored for GLP-1 users. Already launched in the U.S. with Boost Advanced Nutrition and Milo PRO in Asia/Australia, their strategy combines patented ingredient blends, flavor tweaks for dulled taste, and predictive AI tools like Food Genie to optimize recipes and consumer appeal—capitalizing on the 16 million Americans already on these drugs and counting.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
